Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug

Int Ophthalmol Clin. 2006 Fall;46(4):21-40. doi: 10.1097/01.iio.0000212134.83513.11.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Benzophenones / administration & dosage*
  • Benzophenones / pharmacokinetics
  • Benzophenones / therapeutic use
  • Bromobenzenes / administration & dosage*
  • Bromobenzenes / pharmacokinetics
  • Bromobenzenes / therapeutic use
  • Drug Administration Schedule
  • Endophthalmitis / drug therapy*
  • Endophthalmitis / metabolism
  • Humans
  • Ophthalmic Solutions
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Benzophenones
  • Bromobenzenes
  • Ophthalmic Solutions
  • bromfenac